Stock Movers

On this episode of Stock Movers:
SpaceX (SPCX) shares fell after the company disclosed higher-than-expected spending on its artificial intelligence business. The company’s capital expenditures soared to $28.5 billion in the first half of the year, with the vast majority of expenditures steered toward AI. SpaceX generated $3.38 billion in revenue from artificial intelligence during the first six months of the year, less than half what its connectivity business brought in during that span.
Eli Lilly (LLY) shares jump. Eli Lilly & Co. boosted its 2026 sales guidance after its weight-loss drug franchise performed far better than expected in the second quarter. Sales for the year are forecast to be between $85 billion and $87 billion, with second-quarter adjusted earnings and revenue beating Wall Street estimates.
Davita (DVA) shares slide. The kidney dialysis center operator reported weaker-than-expected US dialysis revenue. The firm also reaffirmed its full-year guidance, with the midpoint of the guidance fell below Wall Street’s expectations.
See omnystudio.com/listener for privacy information.

On this episode of Stock Movers:
Advanced Micro Devices (AMD) shares slide. AMD fell after the company gave an underwhelming sales outlook, a sign shareholders expected more of a return from the global expansion of AI data centers. Third-quarter revenue will be $13 billion, plus or minus $300 million, according to the chipmaker, though some Wall Street estimates were well north of $13 billion.
SpaceX (SPCX) shares fell after the company disclosed higher-than-expected spending on its artificial intelligence business. The company’s capital expenditures soared to $28.5 billion in the first half of the year, with the vast majority of expenditures steered toward AI. SpaceX generated $3.38 billion in revenue from artificial intelligence during the first six months of the year, less than half what its connectivity business brought in during that span.
Eli Lilly (LLY) shares jump. Eli Lilly & Co. boosted its 2026 sales guidance after its weight-loss drug franchise performed far better than expected in the second quarter. Sales for the year are forecast to be between $85 billion and $87 billion, with second-quarter adjusted earnings and revenue beating Wall Street estimates.
See omnystudio.com/listener for privacy information.

Today's biggest winners and losers in the stock market.
On this episode of Stock Movers:
- Advanced Micro Devices (AMD) shares are lower after the semiconductor firm’s second-quarter revenue and third-quarter sales forecast underwhelmed investors expecting a stronger performance given rising demand.
- Disney (DIS) shares are climbing as profit beat Wall Street estimates in the company’s fiscal third quarter, driven by soaring income from its entertainment division and the resilience of its theme parks in California and Florida.
- Shopify (SHOP) shares are soaring after it reported revenue for the second quarter that beat the average analyst estimate. President Harley Finkelstein said it was a "monster quarter" for the company.
See omnystudio.com/listener for privacy information.

Today's biggest winners and losers in the stock market.
On this episode of Stock Movers:
- SpaceX (SPCX) is taking a dive this morning as Elon Musk’s satellite, space and artificial intelligence conglomerate gave its first quarterly financial report following its blockbuster initial public offering in June. While the company’s revenue beat the average analyst estimate, capital expenditure jumped to about $18.4 billion in the second quarter led by spending in its artificial intelligence unit.
- Advanced Micro Devices (AMD) shares are lower after the semiconductor firm’s second-quarter revenue and third-quarter sales forecast underwhelmed investors expecting a stronger performance given rising demand.
- Disney (DIS) shares are climbing as profit beat Wall Street estimates in the company’s fiscal third quarter, driven by soaring income from its entertainment division and the resilience of its theme parks in California and Florida.
- Eli Lilly (LLY) shares are higher as it raised its 2026 sales guidance after it reported far stronger second-quarter demand than analysts estimated for its weight-loss and diabetes drugs.Sales for the year will be $85 billion to $87 billion, Lilly said on Wednesday, compared with its earlier forecast of $82 billion to $85 billion.
See omnystudio.com/listener for privacy information.

Today's biggest winners and losers in the stock market.
On this episode of Stock Movers:
- Next shares jumped as much as 7.1% after the British fashion and homewares retailer raised its outlook for the third time this fiscal year, following a surge in sales in the second quarter due to warm UK weather and pent-up demand in the Middle East and northern Europe.
- Glencore shares rallied as much as 5.4%, the most in six months, fter the miner reported first-half adjusted Ebitda that beat analyst expectations due to a surge in the price of its most important commodities.
- Heineken shares rise as much as 2.6% after its volumes unexpectedly grew in the second quarter as strong beer demand in Asia and Africa offset persistent weakness in Europe and the Americas.
See omnystudio.com/listener for privacy information.